Efficacy and safety of fenoldopam for the treatment of hypertensive crises in children with kidney disease: a retrospective study
Fenoldopam seems effective and safe for the treatment of hypertensive crises in children with kidney disease, at a starting dose of 0.2 mcg/kg/min. Strict BP monitoring is required to identify possible excessive drop pressure in the first hours of infusion.
Authors
- Nicola Bertazza Partigiani (ORCID: https://orcid.org/0009-0007-6113-9312)
- Marco Daverio (ORCID: https://orcid.org/0000-0002-3127-8836)
- Alessandra Rosalba Brazzale (ORCID: https://orcid.org/0000-0003-1989-2697)
- Enrico Vidal (ORCID: https://orcid.org/0000-0003-3963-0803)
- Davide Meneghesso (ORCID: https://orcid.org/0000-0002-0584-9279)
- Serena Vigezzi (ORCID: https://orcid.org/0000-0003-1181-0220)
- Matteo Tinnirello
Institutions
- University of Udine (IT)
- University of Padua (IT)
Publication Details
- Journal
- Pediatric Nephrology
- Published
- 2024-09-09
- DOI
- https://doi.org/10.1007/s00467-024-06490-7
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Università degli Studi di Padova